A Phase II Study of Oportuzumab Monatox: An Immunotoxin Therapy for Patients with Noninvasive Urothelial Carcinoma In Situ Previously Treated with Bacillus Calmette-Guérin

2012 ◽  
Vol 188 (5) ◽  
pp. 1712-1718 ◽  
Author(s):  
Mark Kowalski ◽  
Jacinthe Guindon ◽  
Louise Brazas ◽  
Celine Moore ◽  
Joycelyn Entwistle ◽  
...  
2019 ◽  
pp. 337-349
Author(s):  
David D’Andrea ◽  
Fred Witjes ◽  
Francesco Soria ◽  
Shahrokh F. Shariat

2008 ◽  
Vol 179 (4S) ◽  
pp. 120-120
Author(s):  
Takahiro Yoneyama ◽  
Hayato Yamamoto ◽  
Akiko Okamoto ◽  
Atsushi Imai ◽  
Ikuya Iwabuchi ◽  
...  

2021 ◽  
Vol 2 (2) ◽  
pp. 70-72
Author(s):  
Amanda M

We review a case of a 70-year-old male with a recurrence of urothelial carcinoma in an ileal neobladder without involvement of the remaining urothelium two years after a radical cystoprostatectomy. This case is extremely rare especially due to the lack of recurrence in the urethra or upper urinary tract. Abbreviations BCG: Bacillus Calmette-Guérin; CIS: Carcinoma in situ; CT: Computerized/computed tomography; NCCN: National Comprehensive Cancer Network; PE: Pulmonary embolism; PET: Positron emission tomography; RC: Radical cystectomy; TURBT: Trans-urethral resection of bladder tumor; UC: Urothelial carcinoma. Keywords: Urothelial carcinoma; Ileal; neobladder; Tumor; Recurrence; Metastasis.


Urology ◽  
2007 ◽  
Vol 70 (3) ◽  
pp. 146
Author(s):  
M. Brausi ◽  
G. Verrini ◽  
M. Gavioli ◽  
G.C. Peracchia ◽  
G. De Luca ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document